| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Revolution Medicines, Inc. | Director | Common Stock | 28.8K | $778K | $27.00 | Jun 16, 2022 | Direct |
| Revolution Medicines, Inc. | Director | Common Stock | 20K | $540K | $27.00 | Jun 16, 2022 | Indirect |
| Revolution Medicines, Inc. | Director | Stock Option (Right to Buy) | 18.4K | Jun 16, 2022 | Direct | ||
| Maze Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 18K | Sep 22, 2025 | Direct | ||
| PLIANT THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 15K | Jun 16, 2022 | Direct | ||
| Decibel Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 10K | Jun 17, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MAZE | Maze Therapeutics, Inc. | Sep 22, 2025 | 1 | $0 | 4 | Sep 24, 2025 | Director |
| MAZE | Maze Therapeutics, Inc. | Aug 17, 2025 | 1 | $0 | 4 | Aug 19, 2025 | Director |
| MAZE | Maze Therapeutics, Inc. | Jan 30, 2025 | 0 | $0 | 3 | Jan 30, 2025 | Director |
| DBTX | Decibel Therapeutics, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director, 10%+ Owner |
| PLRX | PLIANT THERAPEUTICS, INC. | Jun 16, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
| RVMD | Revolution Medicines, Inc. | Jun 16, 2022 | 2 | $0 | 4 | Jun 17, 2022 | Director |
| RVMD | Revolution Medicines, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| PLRX | PLIANT THERAPEUTICS, INC. | Jun 29, 2021 | 1 | $0 | 4 | Jun 30, 2021 | Director |
| RVMD | Revolution Medicines, Inc. | Jun 22, 2021 | 2 | $0 | 4 | Jun 24, 2021 | Director |
| RVMD | Revolution Medicines, Inc. | Jun 3, 2021 | 2 | $0 | 4 | Jun 7, 2021 | Director |
| RVMD | Revolution Medicines, Inc. | May 25, 2021 | 2 | $0 | 4 | May 27, 2021 | Director |